| Authors: |
Xu X; BioPharmaceuticals Market Access and Pricing, AstraZeneca, Gaithersburg, MD; BioPharmaceuticals Global Medical Affairs, AstraZeneca, Gaithersburg, MD., Katial R; BioPharmaceuticals Global MedicalAffairs, AstraZeneca, Gaithersburg, MD., Schaefer C; Product Development & Market Access Consulting, Labcorp Drug Development, Gaithersburg, MD., Szende A; Product Development & Market Access Consulting, Labcorp Drug Development, Leeds, UK., Genofre E; BioPharmaceuticals US Medical Affairs, AstraZeneca, Wilmington, DE., Chung Y; BioPharmaceuticals US Medical Affairs, AstraZeneca, Wilmington, DE. |
